Nationwide Safety Alert: New York-Based Pet Brand Fi Issues Urgent Voluntary Recall for Canine Supplements Over Potential Salmonella Contamination

NEW YORK, N.Y. — Pet owners nationwide are being urged to check their pantries and supplement cabinets following an urgent voluntary recall issued by Fi, a prominent New York-based pet wellness and technology company. The company has announced the immediate recall of two specific dog supplement lines due to the potential risk of Salmonella contamination.

The contamination is reportedly linked to a raw ingredient supplied by an external vendor to Fi’s third-party manufacturing partner. In response to the discovery, the manufacturer has temporarily suspended production of the affected lines while comprehensive root-cause investigations are underway. Fi leadership emphasizes that the recall is being executed out of an abundance of caution to protect the health and safety of both companion animals and their human caretakers.

The recalled products were distributed directly to consumers across the United States via the company’s official website, as well as through major online retail platforms including Amazon and Chewy.com. Regulatory authorities, including the U.S. Food and Drug Administration (FDA), have been notified, and public health officials are advising consumers to immediately cease feeding the affected supplements to their pets.

Main Facts: Understanding the Fi Supplement Recall

The voluntary recall impacts two distinct canine health products distributed in 180-gram containers. Consumers are advised to examine their product labels carefully against the specific lot numbers and Universal Product Codes (UPCs) provided by federal regulators and the manufacturer.

Affected Products Matrix

What is Salmonella?

Salmonella is a pathogenic bacterium capable of causing severe gastrointestinal illness and systemic infections in both humans and animals. While commonly associated with raw poultry and eggs, dry pet foods, treats, and nutritional supplements can also become vectors for the bacteria if raw ingredients are contaminated during processing or if manufacturing facilities lack adequate pathogen kill-steps.

The bacteria are resilient and can survive for extended periods on dry surfaces, pet bowls, storage containers, and human hands. Consequently, the danger extends beyond the animal consuming the product to anyone handling the packaging, cleaning up pet waste, or failing to practice rigorous hygiene after contact with the contaminated material.

Chronology of Events: How the Recall Unfolded

The sequence of events leading up to the public safety announcement highlights the rapid response mechanisms required in modern pet food supply chain management.

• Ingredient Sourcing and Manufacturing: Fi utilized a third-party manufacturing facility that incorporated raw components from an external supplier into batches of canine calming and multi-benefit health supplements.
• Internal Supply Chain Alert: Following routine testing or supplier notifications, indicators suggested that an ingredient utilized in production may have been exposed to or harbored Salmonella bacteria.
• Production Suspension: Upon receiving alerts regarding the compromised ingredient, Fi’s manufacturing partner immediately halted all production lines associated with the affected formulations to isolate the issue and prevent further distribution.
• Risk Assessment and Decision to Recall: Company executives, in consultation with quality assurance teams and regulatory frameworks, determined that a voluntary nationwide recall was necessary to mitigate public health risks.
• Public Notification: Fi initiated direct email notifications to all impacted consumers who purchased the products through direct-to-consumer channels, while simultaneously coordinating with retail giants Amazon and Chewy.com to flag orders and alert buyers.
• Official FDA Announcement: The U.S. Food and Drug Administration published the formal recall notice on its official safety alerts portal, providing the public with comprehensive guidance, identification metrics, and reporting protocols.

Supporting Data: Health Implications and Clinical Manifestations

Pathogen exposure presents unique clinical challenges for both animals and humans. Health authorities stress the importance of recognizing early symptoms to ensure prompt medical or veterinary intervention.

Human Health Risks

Humans handling contaminated pet supplements can become infected—particularly if they touch their faces, prepare food, or fail to wash their hands thoroughly after handling the product, bowls, feeding scoops, or pet waste.

• Common Symptoms: Healthy adults and children infected with Salmonella typically develop symptoms within 12 to 72 hours of exposure. Manifestations include acute nausea, vomiting, abdominal cramping, fever, and diarrhea or bloody diarrhea.
• Severe Complications: In rare cases, Salmonella bacteria can enter the bloodstream, leading to more serious, systemic medical conditions. These include arterial infections (such as infected aneurysms), endocarditis (inflammation of the heart valves), arthritis, muscle pain, eye irritation, and urinary tract symptoms.
• Vulnerable Populations: Infants, the elderly, pregnant women, and immunocompromised individuals (such as those undergoing chemotherapy or living with HIV/AIDS) are at significantly higher risk for severe, life-threatening complications.

Canine Health Risks

Dogs suffering from salmonellosis exhibit distinct clinical signs, though the severity can vary depending on the animal’s age, immune status, and the concentration of bacteria ingested.

• Primary Symptoms: Infected dogs commonly display lethargy, bouts of vomiting, fever, and diarrhea or bloody diarrhea.
• Subtle Indicators: Some pets may show less dramatic symptoms, presenting only with a decreased appetite, intermittent fever, and mild abdominal pain.
• The Carrier State: Crucially, dogs can be infected with Salmonella without showing outward signs of illness. These "asymptomatic carriers" can shed the bacteria in their saliva, feces, and bodily waste, inadvertently infecting other household pets and human family members.

Official Responses and Consumer Action Plan

Fi and federal regulatory bodies have established clear protocols for consumers who find themselves in possession of the recalled supplement lots.

Company Response and Customer Service

Fi has established a dedicated communication channel to assist affected pet owners. Consumers with questions regarding refunds, safe disposal, or health concerns can reach out directly:

• Telephone Support: 1-888-434-3647 (Available 7 days a week, from 10:00 AM to 8:00 PM Eastern Time).
• Email Support: [email protected]

Safe Handling and Disposal Guidelines

Consumers who have purchased either the Fi Calming Supplement for Dogs (Lot 26118) or the Fi 8-in-1 Formula Supplement for Dogs (Lot 26159) should take immediate precautions:

1. Discontinue Use: Immediately stop administering the supplement to your dog or any other animals in your household.
2. Secure the Container: Ensure the lid is tightly sealed to prevent powder dust or residual product from escaping into the environment or contaminating kitchen surfaces.
3. Dispose of Safely: Throw the sealed container directly into an outdoor trash receptacle or a secure bin out of reach of children, wildlife, and other pets. Do not compost the product.
4. Sanitize Surfaces: Thoroughly wash and disinfect all areas that came into contact with the supplement, including measuring scoops, feeding bowls, countertops, and storage bins. Use a bleach-based cleaner or commercial disinfectant effective against foodborne pathogens.
5. Practice Hand Hygiene: Wash your hands thoroughly with soap and warm water for at least 20 seconds immediately after handling the recalled product, cleaning pet areas, or picking up pet waste.

Reporting Adverse Events

The FDA encourages veterinarians and pet owners to report any adverse reactions or quality control issues associated with pet supplements.

• Online Reporting: Adverse events can be submitted directly to the FDA’s Center for Veterinary Medicine Adverse Event Reporting program by completing Form FDA 1932a, accessible online at www.fda.gov/reportanimalae.

Implications: Supply Chain Vulnerabilities and the Future of Pet Wellness Quality Control

The Fi supplement recall underscores broader vulnerabilities within the rapidly expanding pet supplement and wellness market. Unlike traditional commercial pet foods, which are frequently subject to stringent federal oversight and routine inspections, the pet supplement industry operates in a complex regulatory landscape where finished products often rely on intricate supply chains involving multiple third-party ingredient brokers, contract manufacturers, and overseas suppliers.

The Challenge of Ingredient Sourcing

Modern pet supplement brands often market specialized formulations containing complex blends of botanicals, vitamins, probiotics, and specialized proteins. Each ingredient added to a formulation introduces a new point of vulnerability. If an ingredient supplier experiences a lapse in sanitation, quality assurance, or temperature control, pathogens like Salmonella, Listeria, or E. coli can easily propagate and travel downstream into finished goods destined for retail shelves.

In the case of Fi, the prompt suspension of production by the third-party manufacturer indicates an active acknowledgment of supply chain risks. However, industry analysts note that incidents of this nature inevitably place financial and reputational pressure on emerging pet tech and wellness brands that rely on outsourced manufacturing infrastructure.

Evolving Consumer Expectations and Regulatory Scrutiny

As pet humanization continues to drive unprecedented growth in the pet care sector—with owners spending billions annually on preventive health, longevity supplements, and specialized diets—public expectations for safety and transparency have never been higher. Consumers demand pharmaceutical-grade accountability from companies that market health products for beloved companion animals.

Regulatory agencies are likewise increasing their focus on pathogen controls in pet food and supplement manufacturing facilities. Preventative controls mandated under modern food safety legislation require manufacturers to implement rigorous hazard analysis and critical control point (HACCP) plans designed to detect and eliminate biological hazards long before products are packaged and shipped to e-commerce giants like Amazon and Chewy.

Moving Forward

For Fi, navigating this recall successfully will depend heavily on transparent communication, swift customer restitution, and rigorous auditing of its supply chain partners. For pet owners, the incident serves as a sobering reminder of the importance of vigilance, safe food handling practices, and staying informed about product safety alerts in an interconnected global market.

As investigations continue, both consumers and industry stakeholders will be watching closely to see what preventative measures Fi and its manufacturing partners implement to ensure such a contamination event is not repeated. In the meantime, checking pantry shelves and securing affected product lots remains the most critical first line of defense for households nationwide.